Search results for "DISCOVERY"

showing 10 items of 4119 documents

Syntheses of polyfunctionalized resveratrol derivatives using Wittig and Heck protocols

2012

Improved protocols for Wittig reaction and palladium-catalyzed Heck coupling give expedient access to a series of unprecedented polyfunctionalized artificial-resveratrol derivatives. In the modified Wittig protocol, trimethylsilyl was used as a highly valuable protective group of the phenolic functions of starting aromatic materials. A clean O-alkylation of hydroxylated stilbenes with ethylene carbonate was also conducted. Thus, Wittig reaction followed by hydroxyethylation take place one-pot with only carbon dioxide as waste. Additionally, a palladium-catalyzed Heck coupling strategy was developed by using ferrocenyl phosphane ligands, and multi-functionalized hydroxylated stilbenes were o…

chemistry.chemical_compoundchemistryTrimethylsilylReagentHeck reactionOrganic ChemistryDrug DiscoveryWittig reactionOrganic chemistryBiochemistryEthylene carbonateTetrahedron
researchProduct

Rearranged abietane diterpenoids from the root of teucrium polium subsp. vincentinum

1990

Abstract From the root of Teucrium polium subsp. vincentinum (Labiatae) four new rearranged abietane derivatives, teuvincenones A, B, C, and D (1-4, respectively), have been isolated. Two of these compounds, teuvincenones C (3) and D (4), possess a novel hydrocarbon skeleton which contains a cyclopropane ring constituted by the C-3, C-4, and C-18 carbons of the 17(15→16)-abeo-abietane framework. The structures of these diterpenoids were established mainly by spectroscopic means and, in the case of teuvincenones A (1) and C (3), also confirmed by X-ray diffraction analyses.

chemistry.chemical_compoundfoodChemistryStereochemistryChemical structureOrganic ChemistryDrug DiscoveryDiterpeneBiochemistryTeucrium poliumfood.foodAbietaneCyclopropaneTetrahedron
researchProduct

Struktur-Wirkungs-Beziehungen bei Histaminanaloga, 22. Mitt. Absolute Konfiguration und histaminartige Wirkung der enantiomeren α, Nα-Dimethylhistami…

1980

Es werden die Synthesen der enantiomeren α, Nα-Dimethylhistamine (+)—3 und (−)—3, die Ableitung der absoluten Konfiguration sowie die histaminartige Wirksamkeit der Enantiomere am Ileum (H1) und Atrium (H2) des Meerschweinchens beschrieben. Structure-Activity Relationship of Histamine Analogues. XXII: Absolute Configuration and Histamine-like Activity of the Enantiomeric α, Nα-Dimethylhistamines The synthesis of the enantiomeric α, Nα-Dimethylhistamines (+)—3 and (−)—3, the determination of the absolute configuration and the histamine-like activity of the enantiomers on the guinea-pig ileum (H1) and atrium (H2) are reported.

chemistry.chemical_compoundmedicine.anatomical_structureAtrium (architecture)StereochemistryChemistryDrug DiscoverymedicineAbsolute configurationPharmaceutical ScienceIleumEnantiomerHistamineArchiv der Pharmazie
researchProduct

2-Substituierte Histamine 3. Mitt. über Struktur-Wirkungs-Beziehungen bei Histaminanaloga

1974

Es wurden verschiedene 2-substituierte Histaminderivate aus den entsprechenden 2-substituierten Imidazol-4-carbinolen dargestellt und am isolierten Ileum des Meerschweinchens auf ihre histaminartige Wirkung untersucht. 2-Substituted Histamines Some 2-substituted derivatives of histamine were synthesized from 2-substituted imidazole-4-carbinols. The histamine- or antihistamine — like activity of the resulting compounds was tested on isolated guinea pig ileum.

chemistry.chemical_compoundmedicine.anatomical_structureChemistrymedicine.medical_treatmentDrug DiscoverymedicinePharmaceutical ScienceAntihistamineIleumPharmacologyGuinea pig ileumHistamineArchiv der Pharmazie
researchProduct

Struktur-Wirkungs-Beziehungen bei Histaminanaloga, 23. Mitt. Absolute Konfiguration und histaminartige Wirkung der enantiomeren α-Chlormethylhistamin…

1981

Es wird die histaminartige Wirksamkeit der enantiomeren α-Chlormethylhistamine (+)-2a und (−)-2a sowie der Nα-Methyl-α-chlormethylhistamine (+)-2b und (−)-2b am Ileum (H1) und Atrium (H2) des Meerschweinchens beschrieben und die absolute Konfiguration der Enantiomere abgeleitet. Structure-Activity Relationships of Histamine Analogues, XXIII: Absolute Configuration and Histamine-like Activity of the Enantiomeric α-Chloromethylhistamines and Nα-Methyl-α-chloromethylhistamines The histamine-like activities of the enantiomeric α-chloromethylhistamines (+)-2a and (−)-2a and of the Nα-methyl-α-chloromethylhistamines (+)-2b and (−)-2b on the guinea pig ileum (H1) and atrium (H2) are reported. The …

chemistry.chemical_compoundmedicine.anatomical_structurechemistryAtrium (architecture)StereochemistryDrug DiscoverymedicineAbsolute configurationPharmaceutical ScienceIleumEnantiomerGuinea pig ileumHistamineArchiv der Pharmazie
researchProduct

Conformational investigation of α,β‐dehydropeptides. XV: N‐acetyl‐α,β‐dehydroamino acid N ′N ′‐dimethylamides: conformational properties from infrare…

2005

The FTIR spectra were analysed in the region of the nu(s)(N-H), AI(C=O) and nu(s)(Calpha=Cbeta) bands for a series of Ac-DeltaXaa-NMe2, where DeltaXaa = DeltaAla, (Z)-DeltaAbu, (Z)-DeltaLeu, (Z)-DeltaPhe and DeltaVal, to determine a predominant solution conformation of these alpha,beta-dehydropeptide-related molecules. Measurements were taken in CCl4, DCM and MeCN solutions. In the same way, spectra of saturated analogues Ac-Xaa-NMe2, where Xaa = Ala, Abu, Leu, Phe and Val, were investigated. To help interpret the spectroscopic results, conformational maps were calculated by the B3LYP/6-31+G** method. Also, the relative energies of all conformers of the dehydro compounds in vacuo as well as…

conformationStereochemistryProtein ConformationαPeptideamide/π(Ph) interactionBiochemistrySpectral linechemistry.chemical_compoundStructural BiologyAmideDrug DiscoverySpectroscopy Fourier Transform InfraredSide chainMoleculeC5 hydrogen bondFourier transform infrared spectroscopysolute/solvent interactionMolecular BiologyConformational isomerismβ‐dehydroamino acidsPharmacologychemistry.chemical_classificationChemistryHydrogen bondOrganic ChemistryGeneral MedicineModels TheoreticalAmidestheoretical IR frequenciesFTIR spectroscopyMolecular Medicinedensity functional theory calculationsPeptidesJournal of Peptide Science
researchProduct

Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery

2015

Progeria, or Hutchinson-Gilford progeria syndrome (HGPS), is a rare, fatal genetic disease characterized by an appearance of accelerated aging in children. This syndrome is typically caused by mutations in codon 608 (p.G608G) of the LMNA, leading to the production of a mutated form of lamin A precursor called progerin. In HGPS, progerin accumulates in cells causing progressive molecular defects, including nuclear shape abnormalities, chromatin disorganization, damage to DNA and delays in cell proliferation. Here we report how, over the past five years, pluripotent stem cells have provided new insights into the study of HGPS and opened new original therapeutic perspectives to treat the disea…

congenital hereditary and neonatal diseases and abnormalitiesAgingDiseaseBiologymedicine.disease_causeModels BiologicalBiochemistryLMNAProgeriaPluripotent stem cellsDrug DiscoverymedicineHumansInduced pluripotent stem cellMolecular BiologyGeneticsProgeriaMutationintegumentary systemDrug discoverynutritional and metabolic diseasesLamin Type Amedicine.diseaseProgerinChromatinAgeingNeurologyMutationCancer researchBiotechnologyAgeing Research Reviews
researchProduct

Current development of CFTR potentiators in the last decade

2020

Cystic fibrosis (CF) is a genetic disorder produced by the loss of function of CFTR, a main chloride channel involved in transepithelial salt and water transport. CFTR function can be rescued by small molecules called "potentiators" which increase gating activity of CFTR on epithelial surfaces. High throughput screening (HTS) assays allowed the identification of new chemical entities endowed with potentiator properties, further improved through medicinal chemistry optimization. In this review, the most relevant classes of CFTR potentiators developed in the last decade were explored, focusing on structure-activity relationships (SAR) of the different chemical entities, as a useful tool for t…

congenital hereditary and neonatal diseases and abnormalitiesHigh-throughput screeningGlycineComputational biologyQuinolonesVX-770Aminophenols01 natural sciencesCystic fibrosisCystic fibrosisSmall Molecule LibrariesStructure-Activity Relationship03 medical and health sciencesDrug DiscoverymedicineHumansCFTR potentiatorCFTRLoss function030304 developmental biologyPharmacology0303 health sciencesWater transportbiology010405 organic chemistryChemistryOrganic ChemistryCFTR potentiatorsBiological activityGeneral MedicineTriazolesPotentiatormedicine.diseaseCystic fibrosis transmembrane conductance regulator0104 chemical sciencesCystic fibrosiMutationChloride channelbiology.proteinCystic fibrosis transmembrane conductance regulatorEuropean Journal of Medicinal Chemistry
researchProduct

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

2017

Introduction: The administration of factor VIII (FVIII) concentrates on-demand or on long-term prophylaxis is the effective and safe standard of care of patients with hemophilia A (HA). Development of neutralizing antibodies against exogenous FVIII and the short half-life of the current available products remain major challenges. There is currently a great interest towards newer FVIII products with the goal of reducing the inhibitor risk and increasing the half-life. Area covered: In this review, the authors describe the efficacy and safety of rVIII-SingleChain (Lonoctocog alfa), the first and only single chain recombinant FVIII (rFVIII) molecule developed for the prevention and treatment o…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyHaemophiliaStandard of caresingle-chainHaemophilia AClinical BiochemistrySingle chain030204 cardiovascular system & hematologyHaemophiliaHemophilia A03 medical and health sciences0302 clinical medicineLONOCTOCOG ALFAhemic and lymphatic diseasesDrug DiscoverymedicineHumansPharmacologyClinical Trials as TopicFactor VIIIbusiness.industryCoagulantsDrug Discovery3003 Pharmaceutical ScienceRecombinant Proteinmedicine.diseaseRecombinant ProteinsCoagulantbusiness030215 immunologyHalf-LifeHuman
researchProduct

In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models

2011

6 pages, 5 figures. PMID:21730182[PubMed] PMCID: PMC3141925[Available on 2012/1/19]

congenital hereditary and neonatal diseases and abnormalitiesProtein ConformationRNA-binding proteinProtein Serine-Threonine KinasesBiologyMyotonic dystrophyMyotonin-Protein Kinasedrug discoveryMicechemistry.chemical_compoundnon-coding RNA diseasePeptide Librarymedicinal chemistryDrug DiscoveryGene expressionmedicineAnimalsMyotonic DystrophyMBNL1MultidisciplinaryMusclesdisease modelAlternative splicingRNA-Binding ProteinsRNADystrophyBiological Sciencesmedicine.diseaseRNA secondary structureMolecular biologyDNA-Binding ProteinschemistryRNA splicingDrosophilaTrinucleotide Repeat ExpansionOligopeptides
researchProduct